Results 301 to 310 of about 371,247 (318)

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Journal of Clinical Epidemiology, 2009
Merrick Zwarenstein, Andrew D Oxman, Shaun Treweek   +2 more
exaly  

Stroke Outcomes in the COMPASS Trial

Circulation, 2019
Jackie Bosch, Katalin Keltai, Jong-Won Ha   +2 more
exaly  

Trial Objections and Strategies

SSRN Electronic Journal
openaire   +1 more source

Differential Evolution With Composite Trial Vector Generation Strategies and Control Parameters

IEEE Transactions on Evolutionary Computation, 2011
Yong Wang, Zixing Cai, Qingfu Zhang
exaly  

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

American Journal of Epidemiology, 2016
James M Robins, Hernán MIGUEL A
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Cheng-Long Huang, Wen-Fei Li   +2 more
exaly  

Artificial Intelligence for Clinical Trial Design

Trends in Pharmacological Sciences, 2019
Stefan Harrer, Bhavna J Antony, Jianying Hu   +2 more
exaly  

Novel clinical trial designs emerging from the molecular reclassification of cancer

Ca-A Cancer Journal for Clinicians
Mina Nikanjam, Shumei Kato, Jason K Sicklick   +2 more
exaly  

Cancer therapy and the randomized clinical trial: good medicine?

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

Journal of Clinical Epidemiology, 2008
Jesper Brok, KRISTIAN Thorlund, Christian Gluud   +2 more
exaly